Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Double-Blind Trial of Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations

NCT06080165 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06080165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06080165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Double-Blind Trial of Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations
Lead sponsor
Stanford University
Phase
Phase 1/2
Overall status
Withdrawn
Start date
July 31, 2024
Completion date
June 30, 2028
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pten gene mutation, pten hamartoma syndrome, pten hamartoma tumor syndrome